Skip to main content

Vyome Holdings, Inc

HIND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001427570

No open-market purchases or sales by Vyome Holdings, Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $296.5K in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Vyome Holdings, Inc changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of HIND: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders18115−2
Shares660.5K10.0K1.16M+513.0K (+78.9%)
Value$1.90M$29.0K$1.91M+$34.0K (+1.8%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held Vyome Holdings, Inc at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to HIND in Q4 2021
InstitutionSharesValue% of portfolio
Northern Trust Corp33,426$55.0K0.00%
Millennium Management LLC33,713$55.0K0.00%
BlackRock Inc.897$1.00K0.00%

Sold out (5)

Institutions that held Vyome Holdings, Inc at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of HIND in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Two Sigma Investments, LP40,255$116.0K
XTX Topco Ltd26,951$78.0K
Sassicaia Capital Advisers LLC10,000$29.0K
Bank of America Corp9,595$28.0K
Tower Research Capital LLC (TRC)1,842$5.00K

Not filed for Q4 2021 yet (1)

Institutions that held Vyome Holdings, Inc at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HIND in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Mid Atlantic Financial Management Inc10,000$29.0K